BRBR BELLRING BRANDS, INC.
Food and Kindred Products · NYSE · SEC CIK 1772016 · Fiscal year ends 09/30
Financial factors as of 2026-09-30 (2026Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY3.5%
TTM net income YoY-31.8%
TTM EPS YoY-25.6%
Revenue 3-yr CAGR12.9%
Net income 3-yr CAGR-3.8%
Margins
Gross margin26.6%
Operating margin11.6%
Net margin6.1%
FCF margin4.9%
EBITDA margin12.4%
Returns
ROE—
ROA16.5%
ROIC (approx.)35.7%
Asset turnover2.68x
Leverage & solvency
Liabilities / assets150.3%
Debt / equity—
Current ratio3.20x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.85x
Accruals ratio2.4%
Payout ratio—
Capex / revenue0.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-09-30 | FY20252025-09-30 |
|---|---|---|
| Income statement | ||
| Revenue | $2.40B | $2.32B |
| Cost of revenue | $1.76B | $1.55B |
| Gross profit | $638.10M | $770.40M |
| R&D expense | $13.60M | $16.00M |
| SG&A expense | $343.40M | $396.00M |
| Operating income | $277.70M | $357.40M |
| Interest expense | — | $68.40M |
| Pretax income | $197.70M | $289.00M |
| Income tax | $50.30M | $72.80M |
| Net income | $147.40M | $216.20M |
| EBITDA | $297.80M | $376.00M |
| EPS (basic) | 1.26 | 1.70 |
| EPS (diluted) | 1.25 | 1.68 |
| Weighted avg. shares (diluted) | 117.60M | 128.50M |
| Balance sheet | ||
| Cash & equivalents | $20.10M | $71.80M |
| Receivables | $214.50M | $223.40M |
| Inventory | $324.50M | $330.40M |
| Current assets | $602.80M | $665.50M |
| PP&E, net | $30.90M | $19.00M |
| Goodwill | $65.90M | $65.90M |
| Intangibles | $107.90M | $125.00M |
| Total assets | $846.10M | $941.00M |
| Current liabilities | $188.30M | $282.80M |
| Long-term debt | $1.05B | $1.08B |
| Total debt | $1.05B | $1.08B |
| Total liabilities | $1.27B | $1.39B |
| Shareholders' equity | -$425.50M | -$453.90M |
| Net debt | $1.03B | $1.01B |
| Shares outstanding | 116.30M | 120.80M |
| Cash flow statement | ||
| Operating cash flow | $126.00M | $260.60M |
| Capital expenditure | $9.40M | $4.70M |
| Free cash flow | $116.60M | $255.90M |
| Investing cash flow | -$9.40M | -$4.70M |
| Financing cash flow | -$185.50M | -$238.30M |
| Depreciation & amortization | $20.10M | $18.60M |
| Stock-based compensation | $23.50M | $22.10M |
Free plan shows the latest 2 periods; Pro shows all 9 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.